Table 2

Individual genomic alterations in pTa bladder tumors

Type of aberrationLocuspTaaPbPb
G1 (n =40)G2 (n =55)G3 (n =18)(pTaG1 vs. pTaG2)(pTaG2 vs. pTaG3)
Deletions 2q 04 (7)7 (39)NS0.0011
5q 2 (5)2 (4)5 (28)NS0.0025
6q 01 (2)6 (33)NS0.0001
8p 05 (9)5 (28)NS0.0453
9p 14 (35)20 (36)8 (44)NSNS
9q 18 (45)24 (44)7 (39)NSNS
10q 3 (8)1 (2)5 (28)NS0.0005
11p 3 (8)5 (9)3 (17)NSNS
11q 2 (5)4 (7)4 (22)NSNS
18q 2 (5)5 (9)7 (39)NS0.0031
Y c 8 (23)9 (20)4 (29)NSNS
Gains 1q 3 (8)6 (11)3 (17)NSNS
5p 02 (4)5 (28)NS0.0025
7p 05 (9)1 (6)NSNS
7q 06 (11)1 (6)0.0309NS
8q 05 (9)4 (22)NSNS
11q 2 (5)4 (7)0NSNS
15q 1 (3)4 (7)0NSNS
17q 1 (3)9 (17)6 (33)0.0297NS
20q 2 (5)5 (9)6 (33)NS0.0126
  • a Numbers in parentheses represent percentages.

  • b χ2 test.

  • c Calculated for male patients (pTaG1: 35, pTaG2: 45, pTaG3: 14)